NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tribune Therapeutics

Tribune Therapeutics

Private
StockholmHealthcare & Life Scienceshttps://www.tribunetx.com/

Last Round

Series A

Mar 26, 2025

Total Funding Raised

$56.99M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Tribune Therapeutics is a biotechnology company developing a pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryprotein therapeuticsfibrotic diseasesbiotech startuppreclinical developmentCCN protein familyanti-fibroticdrug pipelinetherapeutic candidatebiopharmascar formationdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tribune Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Tribune Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tribune Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 26, 2025
SeedJun 2, 2021

Key People

Founding team and executive leadership

Ole Joergen Kaasboell

Board Observer, Chief Scientific Officer Co-founder

Founding Team

Georg Vo Beiske

Chief Executive Officer

Executive Team

Tribune Therapeutics Investors

Notable investors and investment history

Tribune Therapeutics investors
InvestorRounds
InnovestorSeries A
Inven2Seed, Series A
InvestinorSeries A
HealthCapSeries A, Seed
IndustrifondenSeries A
Novo HoldingsSeries A, Seed
LifeArc VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Monthly visitors grew 99% MoM, reaching 1.2K.

  • Mar 26, 2025

    $40M raised in Seed round.

Tribune Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tribune Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tribune Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm
Employee Range16
Year Founded2020
Last FundingMar 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.